Shareholders
As at 17 February, the number of shares in issue was 31,170,093.
Major shareholders*
As at 17 February 2021, shareholders holding more than 3% of the share capital of Cambridge Cognition Holdings plc were:
Name | No. of ordinary shares | % of existing share capital |
Nigel Wray | 4,851,547 | 15.56% |
Canaccord Genuity Group Inc | 3,116,475 | 10.00% |
Michael Buxton | 2,181,589 | 7.00% |
Brett Gordon | 1,595,000 | 5.12% |
AXA Investment Managers S.A. | 1,557,500 | 5.00% |
W B Nominees | 1,547,500 | 4.96% |
Octopus Investments Nominees Ltd | 1,429,771 | 4.59% |
Lombard Odier | 1,388,889 | 4.45% |
Stephen Perring | 1,016,000 | 3.26% |
*The information in this table is based on publicly notified information and may not represent current holdings.
Directors’ shareholdings
Director | No. of ordinary shares | % of existing share capital |
Nicholas Walters | 300,826 | 0.97% |
Steven Powell | 216,375 | 0.70% |
Matthew Stork | 125,000 | 0.40% |
Debra Leeves | 50,000 | 0.16% |
Total | 692,201 | 2.22% |
Shares not in public hands
In terms of AIM Rules published February 2010 and insofar as it is aware, at 17 February 2021, 18.15% of the Company's AIM Securities was not in public hands.
Restrictions in transfer of AIM securities
There are no restrictions on the transfer of Cambridge Cognition Holdings plc’s AIM securities.
Other exchanges and trading platforms
Cambridge Cognition Holdings plc has not applied or agreed to have any of its securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.
Share this
-
Sign up for alerts
Receive notification of new announcements